Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-label information dissemination for serious illnesses will be studied by AMA board.

Executive Summary

OFF-LABEL USE INFORMATION DISSEMINATION FOR CATASTROPHIC ILLNESS will be studied by the American Medical Association under a resolution adopted by the AMA House of Delegates June 25 at its annual meeting in Chicago. The policy directs the AMA Board of Trustees to prepare "an in-depth study of the scientific, legal and regulatory aspects of this complicated issue," according to materials presented by the Reference Committee on Science & Technology, which recommended the action to the full House.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel